Trial Profile
A Pilot, Open-Label Single Center Trial of TP10 in Pediatric and Adult Patients With C3 Glomerulopathy (C3G)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs CDX 1135 (Primary)
- Indications Membranoproliferative glomerulonephritis
- Focus Pharmacokinetics
- 25 Oct 2016 Status changed from recruiting to withdrawn prior to enrolment due to no recruitment.
- 02 Dec 2014 New trial record